1 October 2026
Latham Advises on Pyxis Oncology’s Up to US$282.6 Million Public Offering
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | Capital Markets | New York |
| Sandy Kugbei Lead | Latham & Watkins LLP | Partner | Capital Markets | New York |
| Katie Mehary | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Jenny Li | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 283m (US$282.6 Million)
- What the figure measures
- Total transaction value
- Client
- Not stated
- Counterparties
- Pyxis Oncology, Inc. (Issuer)